January 24, 2017
Horizon Discovery expects 2016 revenue up 20%
Horizon Discovery Group expects to see 2016 revenues rise for about 20%, as it expects revenue of at least £24.0 million.
Pharmaceuticals, Biotechnology and Life Sciences
Horizon Discovery Group expects to see 2016 revenues rise for about 20%, as it expects revenue of at least £24.0 million.
Alliance Pharma’s revenue for 2016, driven by the acquisition of ex-Sinclair products in December 2015, could be more than double compared to the previous year.